Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2008 1
2009 1
2013 5
2014 2
2015 2
2016 4
2017 3
2018 6
2019 8
2020 7
2021 4
2022 4
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review.
Urzua CA, Herbort CP Jr, Takeuchi M, Schlaen A, Concha-Del-Rio LE, Usui Y, Cuitino L, Papasavvas I. Urzua CA, et al. Among authors: schlaen a. J Ophthalmic Inflamm Infect. 2022 May 12;12(1):17. doi: 10.1186/s12348-022-00293-3. J Ophthalmic Inflamm Infect. 2022. PMID: 35553272 Free PMC article. Review.
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.
Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, Kurup SK, Sheppard J, Schlaen A, Pavesio C, Cimino L, Van Calster J, Camez AA, Kwatra NV, Song AP, Kron M, Tari S, Brézin AP. Nguyen QD, et al. Among authors: schlaen a. Lancet. 2016 Sep 17;388(10050):1183-92. doi: 10.1016/S0140-6736(16)31339-3. Epub 2016 Aug 16. Lancet. 2016. PMID: 27542302 Free article. Clinical Trial.
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study Consensus Group. Agrawal R, et al. Ophthalmology. 2021 Feb;128(2):277-287. doi: 10.1016/j.ophtha.2020.06.052. Epub 2020 Jun 27. Ophthalmology. 2021. PMID: 32603726
Pediatric Posterior Infectious Uveitis.
Curi ALL, de-la-Torre A, Schlaen A, Mahendradas P, Biswas J. Curi ALL, et al. Among authors: schlaen a. Ocul Immunol Inflamm. 2023 Dec;31(10):1944-1954. doi: 10.1080/09273948.2023.2284990. Epub 2023 Dec 14. Ocul Immunol Inflamm. 2023. PMID: 38096404 Review.
Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A systematic review and meta-analysis.
Cifuentes-González C, Rojas-Carabali W, Pérez ÁO, Carvalho É, Valenzuela F, Miguel-Escuder L, Ormaechea MS, Heredia M, Baquero-Ospina P, Adan A, Curi A, Schlaen A, Urzua CA, Couto C, Arellanes L, de-la-Torre A. Cifuentes-González C, et al. Among authors: schlaen a. PLoS One. 2023 Apr 3;18(4):e0283845. doi: 10.1371/journal.pone.0283845. eCollection 2023. PLoS One. 2023. PMID: 37011101 Free PMC article.
Optical Coherence Tomography Findings in Infectious Posterior Uveitis.
Pichi F, Curi ALL, Vasconcelos-Santos DV, Marchese A, Cicinelli MV, Miserocchi E, Schlaen A. Pichi F, et al. Among authors: schlaen a. Ocul Immunol Inflamm. 2022 Apr 3;30(3):652-663. doi: 10.1080/09273948.2022.2032197. Epub 2022 Feb 28. Ocul Immunol Inflamm. 2022. PMID: 35226572 Review.
Epidemiology of Pediatric Uveitis in Argentina.
LaMattina KC, Frick M, López M, Tártara A, Hurtado E, Schlaen A, Couto C. LaMattina KC, et al. Among authors: schlaen a. J Pediatr Ophthalmol Strabismus. 2023 Oct 25:1-5. doi: 10.3928/1081597X-20230829-01. Online ahead of print. J Pediatr Ophthalmol Strabismus. 2023. PMID: 37882185 Free article.
Safety of systemic therapy for noninfectious uveitis.
Ormaechea MS, Hassan M, Onghanseng N, Park JH, Mahajan S, Al-Kirwi KY, Uludag G, Halim MS, Schlaen A, Sepah YJ, Do DV, Nguyen QD. Ormaechea MS, et al. Among authors: schlaen a. Expert Opin Drug Saf. 2019 Dec;18(12):1219-1235. doi: 10.1080/14740338.2019.1692810. Expert Opin Drug Saf. 2019. PMID: 31801415 Review.
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
Suhler EB, Jaffe GJ, Fortin E, Lim LL, Merrill PT, Dick AD, Brezin AP, Nguyen QD, Thorne JE, Van Calster J, Cimino L, Adan A, Goto H, Kaburaki T, Kramer M, Vitale AT, Kron M, Song AP, Liu J, Pathai S, Douglas KM, Schlaen A, Muccioli C, Van Velthoven MEJ, Zierhut M, Rosenbaum JT. Suhler EB, et al. Among authors: schlaen a. Ophthalmology. 2021 Jun;128(6):899-909. doi: 10.1016/j.ophtha.2020.10.036. Epub 2020 Nov 3. Ophthalmology. 2021. PMID: 33157077 Free article. Clinical Trial.
The Humira in Ocular Inflammations Taper (HOT) Study.
Pichi F, Smith SD, Goldstein DA, Baddar D, Gerges TKA, Janetos TM, Ruiz-Cruz M, Elena Concha-Del-Río L, Maruyama K, Carina Ten Berge J, Rombach SM, Cimino L, Bolletta E, Miserocchi E, Scandale P, Serafino M, Camicione P, Androudi S, Gonzalez-Lopez JJ, Lim LL, Singh N, Gupta V, Gupta N, Amer R, Dodds EM, Inchauspe S, Munk MR, Donicova E, Carreño E, Takeuchi M, Chee SP, Chew MC, Agarwal A, Schlaen A, Gómez RA, Couto CA, Khairallah M, Neri P. Pichi F, et al. Among authors: schlaen a. Am J Ophthalmol. 2024 Feb;258:87-98. doi: 10.1016/j.ajo.2023.09.012. Epub 2023 Sep 19. Am J Ophthalmol. 2024. PMID: 37734639
48 results